June 19, 2018 / 12:59 PM / 4 months ago

BUZZ-Amphastar: Jumps after FDA approves heart block injection

** Drugmaker’s shares climb 15 pct to $19.37 premarket

** FDA approves AMPH’s isoproterenol hydrochloride injection to treat mild, transient episodes of heart block that do not require electric shock or pacemaker therapy, among other things

** Company expects to launch product in Q3

** FDA determined newly approved product to be therapeutically equivalent to Valeant’s Isuprel

** U.S.-listed shares of VRX slipped 1.8 pct premarket

** AMPH down 13 pct this year (Reporting by Amy Caren Daniel in Bengaluru)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below